ARCHIVES

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

In Brief: Friedman Leads FDA During Search; Mead Retires From NCI; Freireich Honored

March 14, 1997

Omnibus bill recissions would cut $28 million from NCI FY04 budget.

January 9, 2004

Jane Henney Said Tentative Choice For FDA Commissioner

May 22, 1998

In Brief: Walter To Retire, Search Starts For New DEA Deputy; Mary Fink Retires; NCCP Seeks Director

January 27, 1984

HEW Approves New Cancer Clinical Education Grants, Without Trainee Stipends ; $4 Million Available In ’75

April 26, 1974

Anil Potti Joins Myrtle Beach Private Practice.

June 3, 2011